Show simple item record

dc.contributor.authorArtac, Mehmet
dc.contributor.authorCoskun, Hasan Senol
dc.contributor.authorErman, Mustafa
dc.contributor.authorTural, Deniz
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorOzhan, Nail
dc.contributor.authorAkar, Emre
dc.contributor.authorCakar, Burcu
dc.contributor.authorKostek, Osman
dc.contributor.authorPaksoy, Nail
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorKeskin, Ozge
dc.contributor.authorTurkoz, Fatma Paksoy
dc.contributor.authorOruc, Kerem
dc.contributor.authorBayram, Selami
dc.contributor.authorYilmaz, Ugur
dc.contributor.authorBilgetekin, Irem
dc.contributor.authorYildiz, Birol
dc.contributor.authorKilickap, Saadettin
dc.date.accessioned2021-03-04T08:41:34Z
dc.date.available2021-03-04T08:41:34Z
dc.identifier.citationTural D., Olmez O. F. , Sumbul A. T. , Artac M., Ozhan N., Akar E., Cakar B., Kostek O., Paksoy N., Erman M., et al., "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience", Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38
dc.identifier.othervv_1032021
dc.identifier.otherav_6482fc30-f906-4896-9712-b9d15695c8a1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/69950
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.titleAtezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume38
dc.contributor.firstauthorID2277715


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record